Live from the NIH registry
Studies recruiting near Killeen right now
Top 25 of 107 recruiting studies, sorted by proximity — each links to its official registry page
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Heart Failure (HF)
N/A
Interventional 420 participants sought
Baylor Scott & White Research Institute — Temple, Texas (22.9 mi)
· Sponsor: Aventusoft, LLC.
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
GMG Clinical Research, LLC dba Radiance Clinical Research — Lampasas, Texas (26.8 mi)
· Sponsor: TriGemX Bio, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Randomized Controlled Trial of a Web-Based Moral Elevation Intervention for Veterans With PTSD
Posttraumatic Stress Disorder
N/A
Interventional 250 participants sought
Central Texas Veterans Health Care System, Temple, TX — Temple, Texas (22.9 mi)
· Sponsor: VA Office of Research and Development
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Safety, Tolerability and Efficacy of ION775
Hypertriglyceridemia, Severe Hypertriglyceridemia
Phase 2
Interventional 72 participants sought
Ionis Investigative Site — Lampasas, Texas (26.8 mi)
· Sponsor: Ionis Pharmaceuticals, Inc.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 2, Phase 3
Interventional 982 participants sought
Baylor Scott & White Vasicek Cancer Treatment Center — Temple, Texas (22.9 mi)
· Sponsor: Pfizer
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Lung Diseases, Interstitial
Phase 3
Interventional 440 participants sought
GSK Investigational Site — Temple, Texas (22.9 mi)
· Sponsor: GlaxoSmithKline
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Baylor Scott and White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — Lampasas, Texas (26.8 mi)
· Sponsor: GlaxoSmithKline
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Baylor Scott & White Health — Temple, Texas (22.9 mi)
· Sponsor: Novo Nordisk A/S
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — Temple, Texas (22.9 mi)
· Sponsor: AstraZeneca
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Refractory Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs)
Phase 2
Interventional 90 participants sought
Artiva Investigational Site Woodland — Woodland, Texas (14.7 mi)
· Sponsor: Artiva Biotherapeutics, Inc.
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Colorectal Cancer
Phase 2
Interventional 144 participants sought
Baylor Scott & White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Ono Pharmaceutical Co., Ltd.
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
Posttraumatic Stress Disorder (PTSD), Suicidal Ideation
N/A
Interventional 190 participants sought
Carl R. Darnall Army Medical Center — Fort Hood, Texas (12.5 mi)
· Sponsor: Ohio State University
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Neoplasms
Phase 2, Phase 3
Interventional 1,541 participants sought
Local Institution - 01033 — Temple, Texas (22.9 mi)
· Sponsor: Celgene
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Baylor Scott and White Research — Temple, Texas (22.9 mi)
· Sponsor: Novartis Pharmaceuticals
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Rectal Cancer
Phase 3
Interventional 250 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Canadian Cancer Trials Group
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
Aging, Preventive Care
N/A
Interventional 7,140 participants sought
Baylor Scott & White Health — Temple, Texas (22.9 mi)
· Sponsor: Massachusetts General Hospital
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Intestinal Neoplasms, Gastrointestinal Neoplasms
Phase 3
Interventional 800 participants sought
Baylor Scott & White Medical Center-Temple — Temple, Texas (22.9 mi)
· Sponsor: Pfizer
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma
Phase 2
Interventional 160 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Children's Oncology Group